Clinical Trial Details
| Trial ID: | L5232 |
| Source ID: | NCT01588743 |
| Associated Drug: | Insulin Aspart |
| Title: | Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Patients |
| Acronym: | |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: insulin aspart |
| Outcome Measures: | Primary: AUC75-120 of Glucose Infusion Rate (GIR), after 2 weeks insulin pump intensive therapy, and one-year follow-up after termination of treatments | Secondary: AUC0-10 of Acute Insulin Response (AIR) during IVGTT, after 2 weeks insulin pump intensive therapy, and one-year follow-up after termination of treatments |
| Sponsor/Collaborators: | Sponsor: Li Guangwei |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | |
| Enrollment: | 130 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2008-10 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2012-05-01 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT01588743 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|